Articles By Julia Barajas
Cannabis and hemp industry members have been awaiting clarity on the legality of hemp-derived CBD products following the passage of the 2018 Farm Bill that legalized hemp.
Member States need “more time to consider the recommendations" of the World Health Organization that acknowledge the therapeutic potential of cannabis.
Commissioner Scott Gottlieb's resignation this week spurred uncertainty, concerns over delays in the rollout of regulations for the hemp-derived CBD industry.
The International Narcotics Control Board report comes on the heels of the WHO’s recommendation that cannabis be rescheduled, and days before member states meet in Vienna to discuss drug policy.
From California to New York, state regulators and the FDA are pushing back against this major trend. Do they have the muscle?
Passage could lead to substantive changes in cannabis research, taxation, banking and public safety.
The vote could ultimately lead to the introduction of a legislative proposal on medical cannabis at the EU level.
Members of the Mexican Senate will soon grapple with three initiatives to regulate the “non-medicinal consumption of cannabis.”
A nascent industry needs protection, but so do certain neighborhoods.